Trial Profile
A Randomized, Placebo Controlled Trial Of Zoledronic Acid For The Prevention Of Bone Loss In Premenopausal Women With Early Stage Breast Cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 10 Jan 2014 Status changed from active, no longer recruiting to completed according to ClinicalTrials.gov record.
- 18 Dec 2009 Secondary analysis published in the the Journal of Clinical Endocrinology and Metabolism.
- 03 Feb 2009 New trial record